Asia Pacific blood purification equipment market will grow by 6.3% annually with a total addressable market cap of $72.37 billion over 2022-2031 owing to the increasing prevalence of blood-related diseases, rising geriatric population, technological innovations, growing healthcare expenditure, rising adoption of home based healthcare, and the rising health consciousness amid COVID-19 pandemic.
Highlighted with 29 tables and 43 figures, this 99-page report “Asia Pacific Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange Device), Portability (Portable, Stationary), Indication (Renal Diseases, Sepsis, Others), End User (Hospitals and Clinics, Dialysis Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific blood purification equipment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific blood purification equipment market in every aspect of the classification from perspectives of Product, Portability, Indication, End User, and Country.
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Portability, Indication, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Highlighted with 29 tables and 43 figures, this 99-page report “Asia Pacific Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange Device), Portability (Portable, Stationary), Indication (Renal Diseases, Sepsis, Others), End User (Hospitals and Clinics, Dialysis Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific blood purification equipment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific blood purification equipment market in every aspect of the classification from perspectives of Product, Portability, Indication, End User, and Country.
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Hemodialysis Device
- Blood Filtration Device
- CRRT Device
- Hemoperfusion Device
- Plasma Exchange Device
- Other Products
Based on Portability, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Portable Equipment
- Stationary Equipment
Based on Indication, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Renal Diseases
- Sepsis
- Other Indications
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Hospitals and Clinics
- Dialysis Centers
- Other End Users
Geographically, the following national/local markets are fully investigated:
- Japan
- China
- South Korea
- Australia
- India
- Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Portability, Indication, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
- Aethlon Medical, Inc.
- Asahi Kasei Corporation
- B. Braun Melsungen AG
- Baxter International Inc.
- Cerus Corporation
- CytoSorbents Corporation
- Fresenius SE and Co. KGaA
- Healthwell Medical Tech. Co., Ltd.
- Infomed SA
- Jafron Biomedical Co., Ltd.
- Kaneka Corporation
- Nikkiso Co., Ltd.
- Spectral Medical Inc.
- SWS Medical Group
Frequently Asked Questions about the Asian Pacific Blood Purification Equipment Market
What is the estimated value of the Asian Pacific Blood Purification Equipment Market?
What is the growth rate of the Asian Pacific Blood Purification Equipment Market?
What is the forecasted size of the Asian Pacific Blood Purification Equipment Market?
Who are the key companies in the Asian Pacific Blood Purification Equipment Market?
Report Attribute | Details |
---|---|
No. of Pages | 99 |
Published | January 2022 |
Forecast Period | 2021 - 2031 |
Estimated Market Value ( USD | $ 5091.7 Million |
Forecasted Market Value ( USD | $ 9356.4 Million |
Compound Annual Growth Rate | 6.3% |
Regions Covered | Asia Pacific |
Table of Contents
1 Introduction
2 Market Overview and Dynamics
3 Segmentation of Asia Pacific Market by Product
4 Segmentation of Asia Pacific Market by Portability
5 Segmentation of Asia Pacific Market by Indication
6 Segmentation of Asia Pacific Market by End User
7 Asia-Pacific Market 2021-2031 by Country
8 Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Aethlon Medical, Inc.
- Asahi Kasei Corporation
- B. Braun Melsungen AG
- Baxter International Inc.
- Cerus Corporation
- CytoSorbents Corporation
- Fresenius SE and Co. KGaA
- Healthwell Medical Tech. Co., Ltd.
- Infomed SA
- Jafron Biomedical Co., Ltd.
- Kaneka Corporation
- Nikkiso Co., Ltd.
- Spectral Medical Inc.
- SWS Medical Group
Methodology
LOADING...